Sam Nguyen, Ph.D., is a partner with Hamilton DeSanctis & Cha LLP. Prior to joining Hamilton, DeSanctis & Cha LLP, Sam was a partner in the Intellectual Property Department at Foley & Lardner LLP. Sam focuses his practice on the preparation and prosecution of U.S. and international pharmaceutical and biotechnology related patent applications, including small molecules, therapeutic peptides and proteins, nucleic acids (compositions of matter, processes, methods of use, articles of manufacture) and material science. Sam is experienced with conducting due diligence and review of patent portfolios for corporations and venture capitalists (IPOs, capital investment, merger and buyout). Sam is also experienced with the preparation of validity, non-infringement and freedom to operate opinions; rendering legal opinions relating to inventorship and license contract disputes; providing strategic IP counseling (management, licensing, best practices for patent procurement, alignment of IP portfolio with business strategy) for domestic and international patent portfolios; and providing state and federal regulatory counseling to multinational pharmaceutical corporations. Sam has over 10 years of experience in pharmaceutical research.

Sam earned his J.D. from the University of Denver in 1997, and his Ph.D. in chemistry from the University of California, Santa Barbara in 1986. He was a postdoctoral fellow at the University of California, Berkeley from 1986-1988.

Sam is admitted to practice in California and Colorado, and before the United States Court of Appeals for the Ninth Circuit; the United States District Court for the Northern District of California; and is registered to practice before the U.S. Patent and Trademark Office. He is a member of the American Bar Association, American Intellectual Property Law Association, American Chemical Society and the Colorado Bar Association.